Drug Profile
Tramadol extended release - Altus Formulation
Alternative Names: TramaFlex ERLatest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator Altus Formulation Inc
- Class Anisoles; Antidepressants; Cyclohexanols; Dimethylamines; Erectile dysfunction therapies; Opioid analgesics; Small molecules
- Mechanism of Action Opioid mu receptor agonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Pain in Canada (PO, Controlled release)
- 29 Jul 2016 Tramadol extended release - Altus Formulation is available for licensing- http://altusformulation.com/wp-content/uploads/2016/05/Tramaflex-overview-N.America-and-Europe.pdf
- 29 Jul 2016 Early research in Pain in Canada (PO)